跳至主要内容
临床试验/CTRI/2020/11/029250
CTRI/2020/11/029250招募中3 期

Study of effect Mahanilavari Anjan in management of Avarana Shukla with special reference to corneal opacity

MGACH and RC Salod At post Wardha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients of 25-50 years of age were selected irrespective of sex, socioeconomic status and religion
  • 2 The chronicity of the disease less than 5 years.
  • 3 Grade 1 & 2 corneal opacities

排除标准

  • 1 Savrana Shukla
  • 5. Grade 3 corneal opacity
  • 2 Associated with diabetes, hypertension malignancy and acute specific infectious systemic disease
  • 3 Contra- indication for Anjana
  • 4 Corneal opacities with other complications like adherent leucoma, corneal facet, kerectasia and anterior staphyloma etc

研究者

发起方
MGACH and RC Salod At post Wardha

相似试验